Rachel C Nolan1, Steven L Galetta, Teresa C Frohman, Elliot M Frohman, Peter A Calabresi, Carmen Castrillo-Viguera, Diego Cadavid, Laura J Balcer. 1. Departments of Neurology (RCN, SLG, and LJB), Population Health (LJB), and Ophthalmology (SLG and LJB), New York University School of Medicine, New York, New York; Department of Neurology (TCF and EMF), Dell Medical School at University of Texas Austin, Austin, Texas; Department of Neurology (PAC), Johns Hopkins University School of Medicine, Baltimore, Maryland; Clinical Development Department (CCV), Biogen, Cambridge, Massachusetts; and Clinical Development Group (DC), Fulcrum Therapeutics, Cambridge, Massachusetts.
Abstract
BACKGROUND: The optic nerve is a frequent site for involvement in multiple sclerosis (MS). Optical coherence tomography (OCT) detects thinning of the retinal nerve fiber layer (RNFL) in eyes of patients with MS and in those meeting criteria for clinically or radiologically isolated demyelinating syndromes. Current international diagnostic criteria for MS do not include the optic nerve as an imaging lesion site despite the high prevalence of acute optic neuritis (ON), or occult optic neuropathy, among early MS and clinically isolated syndrome patients; as well as most MS patients over the course of the disease. We sought to determine optimal thresholds for intereye difference in peripapillary RNFL thickness that are most predictive of a unilateral optic nerve lesion. METHODS: We analyzed spectral domain OCT data of 31 healthy volunteers and 124 patients with MS at a single center as part of an ongoing collaborative investigation of visual outcomes. Intereye differences in peripapillary (360°) RNFL thickness were calculated as the absolute value of the difference. First, we determined the 95th percentile value of intereye difference for the healthy volunteers. This value was applied to the convenience sample group of MS patients as a validation cohort determining how well this threshold could distinguish patients with vs without a history of unilateral ON. The relation of intereye differences in peripapillary RNFL thickness to binocular low-contrast letter acuity scores was also examined. RESULTS: Among healthy volunteer participants (n = 31), the 95th percentile value for intereye difference (upper boundary of expected for normal controls) was 6.0 μm. This value was applied to the convenience sample group of MS patients (n = 124, validation cohort). Positive predictive value, negative predictive value, sensitivity, and specificity for identifying MS patients with a history of unilateral ON were calculated for the 6-μm threshold value in a 2 × 2 table analysis with the application of χ tests (P < 0.0001). The 6-μm threshold was predictive of worse binocular low-contrast acuity scores at 2.5% (P = 0.03) and 1.25% (P = 0.002 by linear regression analyses). A receiver operating characteristic curve analysis demonstrated an optimal intereye difference threshold of 5 μm for identifying unilateral ON in the MS cohort. CONCLUSIONS: An intereye difference of 5-6 μm in RNFL thickness is a robust structural threshold for identifying the presence of a unilateral optic nerve lesion in MS.
BACKGROUND: The optic nerve is a frequent site for involvement in multiple sclerosis (MS). Optical coherence tomography (OCT) detects thinning of the retinal nerve fiber layer (RNFL) in eyes of patients with MS and in those meeting criteria for clinically or radiologically isolated demyelinating syndromes. Current international diagnostic criteria for MS do not include the optic nerve as an imaging lesion site despite the high prevalence of acute optic neuritis (ON), or occult optic neuropathy, among early MS and clinically isolated syndrome patients; as well as most MS patients over the course of the disease. We sought to determine optimal thresholds for intereye difference in peripapillary RNFL thickness that are most predictive of a unilateral optic nerve lesion. METHODS: We analyzed spectral domain OCT data of 31 healthy volunteers and 124 patients with MS at a single center as part of an ongoing collaborative investigation of visual outcomes. Intereye differences in peripapillary (360°) RNFL thickness were calculated as the absolute value of the difference. First, we determined the 95th percentile value of intereye difference for the healthy volunteers. This value was applied to the convenience sample group of MS patients as a validation cohort determining how well this threshold could distinguish patients with vs without a history of unilateral ON. The relation of intereye differences in peripapillary RNFL thickness to binocular low-contrast letter acuity scores was also examined. RESULTS: Among healthy volunteer participants (n = 31), the 95th percentile value for intereye difference (upper boundary of expected for normal controls) was 6.0 μm. This value was applied to the convenience sample group of MS patients (n = 124, validation cohort). Positive predictive value, negative predictive value, sensitivity, and specificity for identifying MS patients with a history of unilateral ON were calculated for the 6-μm threshold value in a 2 × 2 table analysis with the application of χ tests (P < 0.0001). The 6-μm threshold was predictive of worse binocular low-contrast acuity scores at 2.5% (P = 0.03) and 1.25% (P = 0.002 by linear regression analyses). A receiver operating characteristic curve analysis demonstrated an optimal intereye difference threshold of 5 μm for identifying unilateral ON in the MS cohort. CONCLUSIONS: An intereye difference of 5-6 μm in RNFL thickness is a robust structural threshold for identifying the presence of a unilateral optic nerve lesion in MS.
Authors: M L Baier; G R Cutter; R A Rudick; D Miller; J A Cohen; B Weinstock-Guttman; M Mass; L J Balcer Journal: Neurology Date: 2005-03-22 Impact factor: 9.910
Authors: Diego Cadavid; Laura Balcer; Steven Galetta; Orhan Aktas; Tjalf Ziemssen; Ludo Vanopdenbosch; Jette Frederiksen; Mark Skeen; Glenn J Jaffe; Helmut Butzkueven; Focke Ziemssen; Luca Massacesi; Yi Chai; Lei Xu; Stefanie Freeman Journal: Lancet Neurol Date: 2017-02-15 Impact factor: 44.182
Authors: J Toledo; J Sepulcre; A Salinas-Alaman; A García-Layana; M Murie-Fernandez; B Bejarano; P Villoslada Journal: Mult Scler Date: 2008-06-23 Impact factor: 6.312
Authors: E M Mowry; M J Loguidice; A B Daniels; D A Jacobs; C E Markowitz; S L Galetta; M L Nano-Schiavi; G R Cutter; M G Maguire; L J Balcer Journal: J Neurol Neurosurg Psychiatry Date: 2009-02-23 Impact factor: 10.154
Authors: Jeffrey M Gelfand; Douglas S Goodin; W John Boscardin; Rachel Nolan; Ami Cuneo; Ari J Green Journal: PLoS One Date: 2012-05-23 Impact factor: 3.240
Authors: Rachel C Kenney; Mengling Liu; Lisena Hasanaj; Binu Joseph; Abdullah Abu Al-Hassan; Lisanne J Balk; Raed Behbehani; Alexander Brandt; Peter A Calabresi; Elliot Frohman; Teresa C Frohman; Joachim Havla; Bernhard Hemmer; Hong Jiang; Benjamin Knier; Thomas Korn; Letizia Leocani; Elena Hernandez Martinez-Lapiscina; Athina Papadopoulou; Friedemann Paul; Axel Petzold; Marco Pisa; Pablo Villoslada; Hanna Zimmermann; Lorna E Thorpe; Hiroshi Ishikawa; Joel S Schuman; Gadi Wollstein; Yu Chen; Shiv Saidha; Steven Galetta; Laura J Balcer Journal: Neurology Date: 2022-06-28 Impact factor: 11.800
Authors: Laura J Balcer; Lisanne J Balk; Alexander U Brandt; Peter A Calabresi; Elena H Martinez-Lapiscina; Rachel C Nolan; Friedemann Paul; Axel Petzold; Shiv Saidha Journal: J Neuroophthalmol Date: 2018-12 Impact factor: 3.042
Authors: Alissa Rothman; Olwen C Murphy; Kathryn C Fitzgerald; Julia Button; Eliza Gordon-Lipkin; John N Ratchford; Scott D Newsome; Ellen M Mowry; Elias S Sotirchos; Stephanie B Syc-Mazurek; James Nguyen; Natalia Gonzalez Caldito; Laura J Balcer; Elliot M Frohman; Teresa C Frohman; Daniel S Reich; Ciprian Crainiceanu; Shiv Saidha; Peter A Calabresi Journal: Ann Clin Transl Neurol Date: 2019-01-19 Impact factor: 4.511
Authors: Diego Cadavid; Laura Balcer; Steven Galetta; Orhan Aktas; Tjalf Ziemssen; Ludo J Vanopdenbosch; Letizia Leocani; Mark S Freedman; Gordon T Plant; Jana Lizrova Preiningerova; Focke Ziemssen; Luca Massacesi; Yi Chai; Lei Xu Journal: Ann Clin Transl Neurol Date: 2018-08-15 Impact factor: 4.511